524.     Zhang XY, Zhang XD, Borrow JM, Nguyen T, Hersey P. Translational control of tumor necrosis factor-related apoptosis-inducing ligand death receptor expression in melanoma cells. J Biol Chem 2004;279:10606-14.

523.     Zhang XD, Gillespie SK, Borrow JM, Hersey P. The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells. Mol Cancer Ther 2004;3:425-35.

522.     Thompson JF, Stretch JR, Uren RF, Ka VS, Scolyer RA. Sentinel node biopsy for melanoma: Where have we been and where are we going? Ann Surg Oncol 2004;11:147S-51S.

521.     Thompson JF, Shaw HM, Hersey P, Scolyer RA. The history and future of melanoma staging. J Surg Oncol 2004;86:224-35.

520.     Thompson JF, Shaw HM. Editorial: Should Tumor Mitotic Rate and Patient Age, As Well As Tumor Thickness, be Used to Select Melanoma Patients for Sentinel Node Biopsy? Ann Surg Oncol 2004;11:233-5.

519.     Thompson JF, Scolyer RA. Cooperation between surgical oncologists and pathologists: a key element of multidisciplinary care for patients with cancer. Pathology 2004;36:496-503.

518.     Thompson JF, Morton DL. Surgical treatment of systemic metastases: rationale and principles. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:492-4.

517.     Thompson JF, Kam PCA, de Wilt JHW, Lindner P. Isolated limb infusion for melanoma. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:429-37.

516.     Thompson JF, Kam PC. Isolated limb infusion for melanoma: a simple but effective alternative to isolated limb perfusion. J Surg Oncol 2004;88:1-3.

515.     Thompson JF, de Wilt JH. Primary pulmonary melanoma. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:641-7.

514.     Starritt EC, Joseph D, McKinnon JG, Lo SK, de Wilt JH, Thompson JF. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Ann Surg 2004;240:866-74.

513.     Spillane A. Sentinel node biopsy in breast cancer and melanoma requires adequate self-audit. ANZ J Surg 2004;74:308-13.

512.     Shaw HM, Thompson JF. Validity of reported melanoma incidence rates in New Zealand. ANZ J Surg 2004;74:1016-7; author reply 7-8.

511.     Shaw HM, Thompson JF. Cutaneous melanoma in childhood: incidence and prognosis. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:379-86.

510.     Shafren DR, Au GG, Nguyen T, Newcombe NG, Haley ES, Beagley L, Johansson ES, Hersey P, Barry RD. Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus a21. Clin Cancer Res 2004;10:53-60.

509.     Scolyer RA, Zhuang L, Palmer AA, Thompson JF, McCarthy SW. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma. Pathology 2004;36:419-27.

508.     Scolyer RA, Thompson JF, Warnke K, McCarthy SW. Pigmented epithelioid melanocytoma. Am J Surg Pathol 2004;28:1114-5; author reply 5-6.

507.     Scolyer RA, Thompson JF, Stretch JR, Sharma R, McCarthy SW. Pathology of melanocytic lesions: new, controversial, and clinically important issues. J Surg Oncol 2004;86:200-11.

506.     Scolyer RA, Thompson JF, McCarthy SW. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 2004;101:2141-2; author reply 2-3.

505.     Scolyer RA, Thompson JF, Li LX, Beavis A, Dawson M, Doble P, Soper R, Uren RF, Stretch JR, Sharma R, McCarthy SW. Antimony concentrations in nodal tissue can confirm sentinel node identity. Mod Pathol 2004;17:1191-7.

504.     Scolyer RA, Thompson JF, Li LX, Beavis A, Dawson M, Doble P, Ka VS, McKinnon JG, Soper R, Uren RF, Shaw HM, Stretch JR, McCarthy SW. Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: evidence from antimony concentrations in false-negative sentinel nodes from melanoma patients. Ann Surg Oncol 2004;11:174S-8S.

503.     Scolyer RA, McCarthy SW, Elder DE. Frontiers in melanocytic pathology. Pathology 2004;36:385-6.

502.     Scolyer RA, Li LX, McCarthy SW, Shaw HM, Stretch JR, Sharma R, Thompson JF. Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens. Melanoma Res 2004;14:263-8.

501.     Scolyer RA, Li LX, McCarthy SW, Shaw HM, Stretch JR, Sharma R, Thompson JF. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 2004;122:532-9.

500.     Sarris M, Scolyer RA, Konopka M, Thompson JF, Harper CG, Lee SC. Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma. Melanoma Res 2004;14:23-7.

499.     Quinn MJ, Thompson JF. Surgical management of primary melanoma: reconstruction techniques after wide excision. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:255-64.

498.     Pavey S, Johansson P, Packer L, Taylor J, Stark M, Pollock PM, Walker GJ, Boyle GM, Harper U, Cozzi SJ, Hansen K, Yudt L, Schmidt C, Hersey P, Ellem KA, O'Rourke MG, Parsons PG, Meltzer P, Ringner M, Hayward NK. Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene 2004;23:4060-7.

497.     Ollilla DW, McCarthy WH, Felger EA. Therapeutic axillary node dissection for metastatic melanoma. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:273-84.

496.     Nieweg OE, Uren RF, Thompson JF. Sentinel lymph node biopsy: unresolved questions. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:373-8.

495.     Morton DL, Thompson JF. Lymphatic mapping and sentinel lymph node biopsy: the concept. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:307-14.

494.     Menzies SW, Stolz W. Surface microscopy features of melanoma. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:225-33.

493.     Menzies SW, Greenoak GE, Abeywardana CM, Crotty KA, O'Neill ME. UV light from 290 to 325 nm, but not broad-band UVA or visible light, augments the formation of melanocytic nevi in a guinea-pig model for human nevi. J Invest Dermatol 2004;123:354-60.

492.     McCarthy WH, Milton GW. Primary cutaneous melanoma: clinical diagnosis. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:214-24.

491.     McCarthy WH, Kroon BBR. Guidelines for the management of cutaneous melanoma. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:672-79.

490.     McCarthy SW, Scolyer RA, Palmer AA. Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology 2004;36:445-51.

489.     McCarthy SW, Scolyer RA. Melanocytic lesions of the face: diagnostic pitfalls. Ann Acad Med Singapore 2004;33:3-14.

488.     Lindner P, Thompson JF, De Wilt JH, Colman M, Kam PC. Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma. Eur J Surg Oncol 2004;30:433-9.

487.     Li LX, Scolyer RA, Crotty KA, Palmer AA, Kril JJ, Thompson JF, McCarthy SW. Reply. Am J Dermatopathol 2004;26:172-3.

486.     Kroon BB, Fraker DL, Vrouenraets BC, Thompson JF. Isolated limb perfusion: results and complications. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:410-28.

485.     Karakousis CP, Thompson JF. Groin and pelvic dissection. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:285-95.

484.     Ishri R, Menzies S, Hersey P, Halliday GM. Rapid downregulation of antigen processing enzymes in ex vivo generated human monocyte derived dendritic cells occur endogenously in extended cultures. Immunol Cell Biol 2004;82:239-46.

483.     Hersey P, Menzies SW, Halliday GM, Nguyen T, Farrelly ML, DeSilva C, Lett M. Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma. Cancer Immunol Immunother 2004;53:125-34.

482.     Henderson M, Thompson JF. Melanoma of the urogenital tract. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:636-40.

481.     Gillespie SK, Zhang XD, Hersey P. Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells. Mol Cancer Ther 2004;3:1651-8.

480.     Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 2004;11:426-33.

479.     Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004;22:1293-300.

478.     Essner R, Thompson JF, Nieweg OE. The sentinel lymph node biopsy procedure: identification with blue dye and a gamma probe. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:323-38.

477.     Doubrovsky A, De Wilt JH, Scolyer RA, McCarthy WH, Thompson JF. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 2004;11:829-36.

476.     De Wilt JH, Thompson JF, Uren RF, Ka VS, Scolyer RA, McCarthy WH, O'Brien CJ, Quinn MJ, Shannon KF. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 2004;239:544-52.

475.     De Wilt JH, Thompson JF. Is there a role for isolated limb perfusion with tumor necrosis factor in patients with melanoma? Ann Surg Oncol 2004;11:119-21.

474.     Dahlstrom JE, Scolyer RA, Thompson JF, Jain S. Spitz naevus: diagnostic problems and their management implications. Pathology 2004;36:452-7.

473.     Crotty KA, Menzies SW. Dermoscopy and its role in diagnosing melanocytic lesions: a guide for pathologists. Pathology 2004;36:470-7.

472.     Bonenkamp JJ, Thompson JF, de Wilt JH, Doubrovsky A, de Faria Lima R, Kam PC. Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence. Eur J Surg Oncol 2004;30:1107-12.

471.     Binder M, Menzies SW. Computer aided instrumentation for the diagnosis of primary melanoma. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:234-40.

470.     Bilchik A, Essner R, Thompson JF, Morton DL. Hepatic surgery for metastatic melanoma. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:505-13.

469.     Balch CM, Soong SJ, Thompson JF. The natural history of melanoma and factors predicting its outcome. In: Thompson JF, Morton DL, Kroon BB, eds. Textbook of Melanoma. London: Martin Dunitz; 2004:181-98.

468.     Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A, Jr., Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004;54:131-49; quiz 82-4.

467.     Allen BJ, Raja C, Rizvi S, Li Y, Tsui W, Zhang D, Song E, Qu CF, Kearsley J, Graham P, Thompson J. Targeted alpha therapy for cancer. Phys Med Biol 2004;49:3703-12.

466.     Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, Kopf AW, Polsky D. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. Jama 2004;292:2771-6.